Crinetics Pharmaceuticals (CRNX) Cash from Operations (2017 - 2026)

Crinetics Pharmaceuticals' Cash from Operations history runs 10 years deep, the most recent figure standing at 124703000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 40.98% year-over-year to 124703000.0; the TTM figure through Mar 2026 stood at 414173000.0 (down 55.83% YoY), while the FY2025 annual figure was 377922000.0, down 64.18% from the prior year.
• Cash from Operations was 124703000.0 for Q1 2026 at Crinetics Pharmaceuticals, down from 92901000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 13543000.0 in Q1 2022 to a low of 124703000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 59801294.12 across 5 years, with a median of 47644000.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Cash from Operations surged 32.51% in 2022, then sank 200.66% in 2023.
• A 5-year view of Cash from Operations shows it stood at 35207000.0 in 2022, then fell by 15.9% to 40806000.0 in 2023, then slumped by 63.88% to 66871000.0 in 2024, then sank by 38.93% to 92901000.0 in 2025, then sank by 34.23% to 124703000.0 in 2026.
• The last three Cash from Operations figures came in at 124703000.0 (Q1 2026), 92901000.0 (Q4 2025), and 110718000.0 (Q3 2025), per Business Quant data.